[go: up one dir, main page]

TN2013000035A1 - Highly crystalline valsartan - Google Patents

Highly crystalline valsartan

Info

Publication number
TN2013000035A1
TN2013000035A1 TNP2013000035A TN2013000035A TN2013000035A1 TN 2013000035 A1 TN2013000035 A1 TN 2013000035A1 TN P2013000035 A TNP2013000035 A TN P2013000035A TN 2013000035 A TN2013000035 A TN 2013000035A TN 2013000035 A1 TN2013000035 A1 TN 2013000035A1
Authority
TN
Tunisia
Prior art keywords
highly crystalline
crystalline valsartan
valsartan
preparation
pharmaceutical compositions
Prior art date
Application number
TNP2013000035A
Other languages
French (fr)
Inventor
Ricardo Schneeberger
Jens Burgbacher
Bjorn Thomas Hahn
Florian Andreas Rampf
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2011/063254 external-priority patent/WO2012016969A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2013000035A1 publication Critical patent/TN2013000035A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention describes a highly crystalline form of valsartan, pharmaceutical compositions thereof and process for the preparation thereof
TNP2013000035A 2011-08-01 2013-01-29 Highly crystalline valsartan TN2013000035A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2011/063254 WO2012016969A1 (en) 2010-08-03 2011-08-01 Highly crystalline valsartan

Publications (1)

Publication Number Publication Date
TN2013000035A1 true TN2013000035A1 (en) 2014-06-25

Family

ID=54360747

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000035A TN2013000035A1 (en) 2011-08-01 2013-01-29 Highly crystalline valsartan

Country Status (1)

Country Link
TN (1) TN2013000035A1 (en)

Similar Documents

Publication Publication Date Title
GEP20247677B (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
ZA201206254B (en) Novel salts for the manufacture of pharmaceutical compositions
EP2706987B8 (en) Pharmaceutical compositions
HUE037747T2 (en) Nanostructured aprepitant compositions, process for the preparation thereof and pharmaceutical compositions containing them
ZA201103820B (en) Process for the preparation of tenofovir
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
MX2014004196A (en) Rasagiline citramide.
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
GB201004876D0 (en) Process for the preparation of vitamin K2
SG11201400939YA (en) Process for the preparation of methoxymelonal
PL2901857T3 (en) Process for the preparation of 3-chloro-4,5,6-trifluoro-picolinonitrile
IN2014DN06964A (en)
PH12013500210A1 (en) Highly crystalline valsartan
IN2014DN09451A (en)
AP2012006280A0 (en) Synthesis process, and crystalline form of 4-ä3-ÄCis-hexahydrocyclopentaÄCÜpyrrol-2(1H)-YLÜpropoxyübenzamide hydrochloride and pharmaceutical compositions containing it.
ZA201308542B (en) Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
EP2776388A4 (en) A novel process for the preparation of (r)-n-benzyl-2 acetamido-3-methoxypropionamide
GB201119690D0 (en) Process for the preparation of compounds
AP3344A (en) New dihydro-oxazolobenzodiazepinone compounds, a process for their preparation and pharmaceutical compositions containing them
PT2702045T (en) Novel process for the preparation of etravirine
ZA201106353B (en) Dihydrobenzoxathiazepine compounds,a process for their preparation and pharmaceutical compositions containing them
PL393916A1 (en) Process for the preparation of carbapenemic compounds
TN2013000035A1 (en) Highly crystalline valsartan
PL2782924T3 (en) Process for the preparation of drospirenone
ZA201107792B (en) Process for the preparation of highly pure duloxetine hydrochloride